These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Mesalazine is effective in Crohn disease 2]. Quartarolo JP; Laegemidler F; Eskerod O Ugeskr Laeger; 2005 Mar; 167(11):1308-9; author reply 1309. PubMed ID: 15830510 [No Abstract] [Full Text] [Related]
27. [Mesalazine is without clinical effect in patients with Crohn disease]. Munck LK Ugeskr Laeger; 2005 Jan; 167(3):302-3. PubMed ID: 15704804 [No Abstract] [Full Text] [Related]
28. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143 [TBL] [Abstract][Full Text] [Related]
29. [A study of 5-ASA use among young patients with Crohn disease. Regular drug revision is of significance for all children with chronic disease]. Hedin A; Ehrsson H; Eksborg S; Finkel Y; Hildebrand H; Lidehäll AK Lakartidningen; 2001 Oct; 98(40):4343-6. PubMed ID: 11685756 [No Abstract] [Full Text] [Related]
30. Medical treatment of inflammatory bowel disease. Singhal A; Kar P J Assoc Physicians India; 1995 Sep; 43(9):627-31. PubMed ID: 8773067 [No Abstract] [Full Text] [Related]
31. [Mesalazine for maintenance of medically-induced remission in Crohn disease: a survey of a Cochrane review]. Thomsen OØ; Nielsen OH Ugeskr Laeger; 2005 Aug; 167(33):3015-7. PubMed ID: 16109240 [No Abstract] [Full Text] [Related]
32. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis. Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857 [TBL] [Abstract][Full Text] [Related]
33. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention. Sandborn WJ Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478 [TBL] [Abstract][Full Text] [Related]
34. Oral balsalazide (Colazal) for ulcerative colitis. Med Lett Drugs Ther; 2001 Jul; 43(1109):62-3. PubMed ID: 11468602 [No Abstract] [Full Text] [Related]